Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$372M |
| 2 |
Cisco
CSCO
|
+$301M |
| 3 |
Walmart Inc
WMT
|
+$273M |
| 4 |
Puma Biotechnology
PBYI
|
+$258M |
| 5 |
IBM
IBM
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$909M |
| 2 |
Amazon
AMZN
|
+$544M |
| 3 |
Coca-Cola
KO
|
+$408M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$319M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.69% |
| 2 | Healthcare | 21.74% |
| 3 | Consumer Staples | 15.63% |
| 4 | Consumer Discretionary | 13.48% |
| 5 | Industrials | 6.09% |
Similar funds
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2015 Portfolio in Review
As of Q2 2015, Grantham, Mayo, Van Otterloo & Co (GMO) held 459 positions worth $31B, down 7.4% from $33.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.32B in Q2 2015, closing 16 positions and reducing 274 holdings. Its most notable exit was LORILLARD INC COM STK, an estimated $68.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Puma Biotechnology worth $167M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2015 buy was Puma Biotechnology: 1,426,738 shares worth $167M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Microsoft in Q2 2015, an estimated $372M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2015 reduction was Express Scripts Holding Company, cutting an estimated $909M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $68.8M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 36% of its $31B portfolio in Q2 2015.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 27 new positions and closed 16 in Q2 2015.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7.4% quarter-over-quarter to $31B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2015, filed 13 Aug 2015.